Sökning: L773:1387 2877 OR L773:1875 8908 >
Anticholinergic Bur...
-
Tan, Edwin C. K.Karolinska Institutet,Stockholms universitet,Centrum för forskning om äldre och åldrande (ARC), (tills m KI),Monash University, Australia
(författare)
Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
-
Stockholm :Karolinska Institutet, Dept of Neurobiology, Care Sciences and Society,2018
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:su-160279
-
ISSN:1387-2877
-
10616/46658hdl
-
https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-160279URI
-
https://doi.org/10.3233/JAD-180353DOI
-
http://hdl.handle.net/10616/46658URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:139064996URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: Anticholinergic burden is associated with poorer cognitive and functional outcomes in people with dementia. However, the impact of anticholinergics on significant adverse outcomes such as stroke has not been studied previously.Objective: To investigate the association between total anticholinergic cognitive burden (ACB) and risk of stroke and death in people with different dementia subtypes.Methods: This was a cohort study of 39,107 people with dementia and no prior history of stroke registered in the Swedish Dementia Registry (SveDem) from 2008-2014. Data were extracted from the Swedish Prescribed Drug Register, the Swedish National Patient Register, and the Swedish Total Population Register. Competing risk regression models were used to compute hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between time-varying ACB score and risk of stroke and all-cause mortality.Results: During a mean follow-up period of 2.31 (standard deviation 1.66) years, 11,224 (28.7%) individuals had a stroke or died. Compared with non-users of anticholinergic medications, ACB score of 1 (HR 1.09, 95% CI 1.04-1.14) and ACB score of >= 2 (HR 1.20, 95% CI 1.14-1.26) increased the risk of developing the composite outcome of stroke and death. When stratifying by dementia disorder, the association remained significant in Alzheimer's disease, mixed dementia, and vascular dementia.Conclusions: The use of anticholinergic medicines may be associated with an increased risk of stroke and death in people with dementia. A dose-response relationship was observed. Careful consideration should be made when prescribing medications with anticholinergic properties to people with dementia.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Eriksdotter, MariaKarolinska Institutet
(författare)
-
Garcia-Ptacek, SaraKarolinska Institutet
(författare)
-
Fastbom, JohanKarolinska Institutet,Stockholms universitet,Centrum för forskning om äldre och åldrande (ARC), (tills m KI)
(författare)
-
Johnell, KristinaKarolinska Institutet,Stockholms universitet,Centrum för forskning om äldre och åldrande (ARC), (tills m KI)
(författare)
-
Stockholms universitetCentrum för forskning om äldre och åldrande (ARC), (tills m KI)
(creator_code:org_t)
-
Karolinska Institutet
-
Karolinska Institutet
Sammanhörande titlar
-
Ingår i:Journal of Alzheimer's DiseaseStockholm : Karolinska Institutet, Dept of Neurobiology, Care Sciences and Society65:2, s. 589-5961387-28771875-8908
Internetlänk
Hitta via bibliotek
Till lärosätets databas